Malta - English - Medicines Authority

mylan pharmaceuticals limited damastown industrial park mulhuddart dublin15 dublin, ireland - piperacillin, tazobactam - powder for solution for infusion or injection - piperacillin 2 g tazobactam 0.25 g - antibacterials for systemic use

Malta - English - Medicines Authority

mylan pharmaceuticals limited damastown industrial park mulhuddart dublin15 dublin, ireland - piperacillin, tazobactam - powder for solution for infusion - piperacillin 4 g tazobactam 0.5 g - antibacterials for systemic use

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - piperacillin sodium 2.085 g equivalent to piperacillin 2g; tazobactam sodium 0.2683 g equivalent to tazobactam 0.25g - powder for injection - active: piperacillin sodium 2.085 g equivalent to piperacillin 2g tazobactam sodium 0.2683 g equivalent to tazobactam 0.25g - piperacillin/ tazobactam is indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of piperacillin/ tazobactam kabi plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: piperacillin/tazobactam kabi is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years: in hospitalised children aged 2 to 12 years, piperacillin/ tazobactam is indicated for the treatment of serious intra-abdominal infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - piperacillin sodium 4.17 g equivalent to piperacillin 4g; tazobactam sodium 0.5366 g equivalent to tazobactam 0.5g - powder for injection - active: piperacillin sodium 4.17 g equivalent to piperacillin 4g tazobactam sodium 0.5366 g equivalent to tazobactam 0.5g - piperacillin/ tazobactam is indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of piperacillin/ tazobactam kabi plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: piperacillin/tazobactam kabi is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years: in hospitalised children aged 2 to 12 years, piperacillin/ tazobactam is indicated for the treatment of serious intra-abdominal infections.

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - piperacillin; tazobactam - powder for solution for infusion - piperacillin and enzyme inhibitor

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - populus tremuloides 1x sabal serrulata 1x apis mellifica 3x baptisia tinctoria 3x camphora 3x capsicum annuum 3x cubeba officinalis 3x equisetum hyemale 3x ononis spinosa 3x rubia tinctorum 3x scrophularia nodosa 3x solidago virgaurea 3x urtica urens 3x uva-ursi 3x petroselinum sativum 4x berberis vulgaris 5x cantharis 5x barosma crenata 6x kreosotum 6x scilla maritima 6x terebinthina 6x mercurius corrosivus 12x - for the temporary relief of constipation, diarrhea, or frequent urination.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - piperacillin monohydrate 4.198 g equivalent to piperacillin sodium 4.2531g equivalent to piperacillin 4.0g;  ; tazobactam 0.5 g equivalent to tazobactam sodium 0.54733g - powder for injection - active: piperacillin monohydrate 4.198 g equivalent to piperacillin sodium 4.2531g equivalent to piperacillin 4.0g   tazobactam 0.5 g equivalent to tazobactam sodium 0.54733g - indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of pipertaz sandoz plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: pipertaz sandoz is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years in hospitalised children aged 2 to 12 years, pipertaz sandoz is indicated for the treatment of serious intra-abdominal infections. it has not been evaluated in this indication for paediatric patients below the age of 2 years.

United States - English - NLM (National Library of Medicine)

x-gen pharmaceuticals, inc. - piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx) - piperacillin anhydrous 3 g in 20 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

stravencon ltd - piperacillin sodium; tazobactam sodium - powder for solution for infusion - 4/0.5 gram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - piperacillin sodium; tazobactam (as sodium salt) - powder for solution for infusion - 4/0.5 gram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor